Day: February 8, 2021

Aktieägarna i NAXS AB (publ), org.nr 556712-2972, med säte i Stockholm (”Bolaget” eller ”NAXS”), kallas härmed till årsstämma torsdagen den 11 mars 2021.Mot bakgrund av den extraordinära situation som råder till följd av covid-19-pandemin kommer NAXS årsstämma att genomföras genom förhandsröstning (poströstning) med stöd av tillfälliga lagregler. Någon stämma med möjlighet att närvara personligen eller genom ombud kommer inte att äga rum; det blir alltså en stämma utan fysiskt deltagande.NAXS välkomnar alla aktieägare att utnyttja sin rösträtt vid årsstämman genom förhandsröstning i den ordning som beskrivs nedan. Information om de vid årsstämman fattade besluten offentliggörs den 11 mars 2021 så snart utfallet av röstningen är slutligt sammanställt.Aktieägarna kan i förhandsröstningsformuläret begära att beslut i något eller några av...

MALVERN, Pa., Feb. 08, 2021 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on therapeutics for acute care settings, (“Baudax Bio” or the “Company”) today announced that it has entered into a definitive agreement with institutional and accredited investors for the purchase and sale of an aggregate of 11,000,000 shares of common stock at a purchase price of $1.60 per share in a registered direct offering priced at-the-market under Nasdaq rules. The closing of the offering is expected to occur on or about February 10, 2021, subject to the satisfaction of customary closing conditions.H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.The gross proceeds to Baudax Bio from the offering are expected to be approximately $17.6 million. Baudax Bio currently intends to...

The ADNAB™ platform was developed and exclusively licensed to Sorrento by the Mayo ClinicClinical studies utilizing the ADNAB™ platform are ongoing at the Mayo Clinic; and are evaluating multiple platform-generated products in advanced-stage: endometrial cancer, ovarian cancer, angiosarcoma, and B-Cell lymphomasStudy LS1681 is a Mayo Investigator-Initiated-Trial (IIT) for relapsed or refractory B-cell lymphomas; and is evaluating rituximab-ADNAB™ (nab-paclitaxel nanoparticles non-covalently coated with rituximab)1Study MC1371 is a Mayo Investigator-Initiated-Trial (IIT) for various solid tumors; and has completed a dose escalation phase2. To date, 9 endometrial and ovarian cancer patients, that had failed at least one prior regimen containing bevacizumab, were treated with bevacizumab-ADNAB™ (nab-paclitaxel nanoparticles non-covalently...

GLENVIEW, Ill., Feb. 08, 2021 (GLOBE NEWSWIRE) — Illinois Tool Works Inc. (NYSE: ITW) today announced its participation in the Barclays Industrial Select Conference on Tuesday, February 16, 2021. Senior Vice President & Chief Financial Officer, Michael Larsen, will present at the conference from 10:50-11:20 a.m. (EST).The event will be webcast live, and a replay will be available, on ITW’s Investor Relations website at https://investor.itw.com.About Illinois Tool WorksITW (NYSE: ITW) is a Fortune 200 global multi-industrial manufacturing leader with revenues totaling $12.6 billion in 2020. The company’s seven industry-leading segments leverage the unique ITW Business Model to drive solid growth with best-in-class margins and returns in markets where highly innovative, customer-focused solutions are required. ITW’s approximately...

WOBURN, Mass., Feb. 08, 2021 (GLOBE NEWSWIRE) — Bridgeline Digital, Inc. (NASDAQ: BLIN), a provider of cloud-based Marketing Technology software, announced today that it will release its financial results for the first quarter 2021 on Thursday, February 11, 2021 at 4:30 p.m. ET. On that day, Ari Kahn, the Company’s President and Chief Executive Officer and Mark G. Downey, the Company’s Chief Financial Officer, plan to host a live conference call at 4:30 p.m. ET to discuss the financial results. A replay will be available for one week following the live call.The details of the conference call and replay are as follows:About Bridgeline DigitalBridgeline helps companies grow online revenues by increasing their traffic, conversion rate, and average order value with its Unbound platform and suite of apps.  To learn more,...

Long-term partnership provides support to athletes and NSOs across CanadaTORONTO, Feb. 08, 2021 (GLOBE NEWSWIRE) — On Monday, the Canadian Olympic Committee (COC) formally announced StorageVault Canada Inc. as the new Official Storage and Moving Partner of Team Canada. The five-year partnership, which began in late 2020 and runs through 2024, will focus on providing residential, office, corporate and industrial storage and moving services to the COC, National Sport Organizations and Team Canada athletes.“The COC is proud to officially welcome StorageVault to the Canadian Olympic family. We are grateful to our dedicated partners for their unwavering support of Team Canada, especially throughout the pandemic,” said COC CEO and Secretary General, David Shoemaker. “StorageVault shares our values of respect, accountability, excellence,...

Le partenariat à long terme offre un soutien aux athlètes et aux ONS de partout au paysTORONTO, 08 févr. 2021 (GLOBE NEWSWIRE) — Lundi, le Comité olympique canadien (COC) a annoncé que StorageVault Canada Inc. était le nouveau Partenaire officiel d’entreposage et de déménagement d’Équipe Canada. Ce partenariat de cinq ans qui a démarré à la fin de 2020 et qui se déroulera jusqu’en 2024 sera axé sur l’offre de services d’entreposage résidentiel, corporatif, industriel et de bureau au COC, aux organismes nationaux de sport et aux athlètes d’Équipe Canada.« Le COC est fier d’accueillir officiellement StorageVault au sein de la famille olympique canadienne. Nous sommes reconnaissants envers nos partenaires dévoués pour leur soutien inébranlable d’Équipe Canada, particulièrement dans le contexte de la pandémie, a déclaré David Shoemaker,...

– IND-Enabling Studies Demonstrated Potential of a Single I.V. Administration of HMI-203 to Address Peripheral and CNS Components of Disease –– Data at WORLDSymposium™ Support Plans to Initiate a HMI-203 Phase 1/2 Clinical TrialThis Year –BEDFORD, Mass., Feb. 08, 2021 (GLOBE NEWSWIRE) — Homology Medicines, Inc. (Nasdaq: FIXX), a clinical-stage genetic medicines company, announced today the first scientific presentation of data from IND-enabling studies with its HMI-203 gene therapy development candidate for Hunter syndrome (MPS II). The results from Homology’s in vivo approach demonstrated the potential of HMI-203 to address peripheral manifestations in the murine disease model and showed that HMI-203 crossed the blood-brain-barrier following a single I.V. administration. These data will be presented during...

AIKEN, S.C., Feb. 08, 2021 (GLOBE NEWSWIRE) — Security Federal Corporation (“Company”) (OTCBB: SFDL), the holding company for Security Federal Bank (“Bank”), today announced earnings and results for the quarter and year ended December 31, 2020.Net income increased $1.5 million, or 91.3%, to $3.1 million, or $0.94 per share, for the quarter ended December 31, 2020, compared to $1.6 million, or $0.54 per share, for the fourth quarter of 2019. The increase in net income was primarily due to a $1.5 million, or 21.6%, increase in net interest income.For the year ended December 31, 2020, net income was $7.1 million, or $2.19 per share, a decrease of $744,000, or 9.5%, compared to $7.8 million, or $2.64 per share, during 2019. The decrease in net income was the result of significantly higher loan loss provisions recorded during 2020 in...

Operations in Q4 2020 heavily impacted by COVID-19 and related travel restrictions with capacity down by 95%Total revenue in Q4 2020 USD 60.2 million decreasing by 81% from last yearCargo revenue increased by 48% year-on-year in fourth quarterEBIT negative of USD 60.2 million in Q4 2020 compared to negative EBIT of USD 36.7 million in Q4 2019Icelandair’s capacity down by 81% in 2020 compared to 2019 and the number of passengers down by 83%Net loss for the full year 2020 USD 376.2 million compared to a net loss of USD 57.8 million in 2019Equity USD 232.8 million at year-end and equity ratio down from 29% to 25%, adjusted for temporary effects of warrantsTotal liquidity USD 331.4 million at year-end 2020, thereof cash and marketable securities USD 159.4 millionDemand for Q1 2021 still weak due to the status of the pandemic in key marketsModest...